Treatment and outcome of 2904 CML patients from the EUTOS population-based registry
Verena Hoffmann(Zimmer Biomet (Germany)), Rüdiger Hehlmann(Heidelberg University), Martin Höglund(Uppsala University), Gianantonio Rosti(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Richard E. Clark(The Football Association), Bo Simonsson(Uppsala University), Susanne Saußele(University of Mannheim), Andrija Bogdanović(University of Belgrade), Zuzana Sninská(University Hospital Bratislava), Tomasz Sacha, Luis Felipe Casado(Complejo Hospitalario Universitario de Toledo), Fausto Castagnetti(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Perttu Koskenvesa(Helsinki University Hospital), Francesco Di Raimondo(University of Catania), Paul Costeas(Deakin University), Andreas Hochhaus(Jena University Hospital), G. Schubert-Fritschle(Ludwig-Maximilians-Universität München), Michele Baccarani(University of Bologna), Hele Everaus(Tartu University Hospital), Sandra Lejniece(Riga East University Hospital), Andrey Zaritskey, Karel Indrák(Palacký University Olomouc), Laimonas Griškevičius(Vilnius University), Dubravka Sertić(University Hospital Centre Zagreb), Joerg Hasford(Ludwig-Maximilians-Universität München), Doris Lindoerfer(Zimmer Biomet (Germany)), G.J. Ossenkoppele(Amsterdam UMC Location Vrije Universiteit Amsterdam), Joëlle Guilhot(Inserm), Irena Zupan(Ljubljana University Medical Centre), Sonja Burgstaller(Klinikum Wels-Grieskirchen), Andrzej Hellmann(Gdańsk Medical University), Anna Turkina(National Medical Research Center for Hematology)
Cited by 104
Related Papers
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
|Leukemia|2022|3.8k
Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
|New England Journal of Medicine|2014|3.5k
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.6k